| Year |
Citation |
Score |
| 2022 |
Rocco MT, Akhter AS, Ehrlich DJ, Scott GC, Lungu C, Munjal V, Aquino A, Lonser RR, Fiandaca MS, Hallett M, Heiss JD, Bankiewicz KS. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of patients with Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35957524 DOI: 10.1016/j.ymthe.2022.08.003 |
0.321 |
|
| 2022 |
Christine CW, Richardson RM, Van Laar A, Fine EM, Khwaja OS, Liang GS, Bankiewicz K, Larson PS. Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology. 99: 260-261. PMID 35940892 DOI: 10.1212/WNL.0000000000201005 |
0.405 |
|
| 2022 |
Christine CW, Richardson RM, Fine EM, Khwaja OS, Liang GS, Meier A, Roberts EW, Bankiewicz K, Larson PS. Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology. 99: 259. PMID 35940891 DOI: 10.1212/WNL.0000000000201003 |
0.405 |
|
| 2021 |
Christine CW, Richardson RM, Van Laar AD, Thompson ME, Fine EM, Khwaja OS, Li C, Liang GS, Meier A, Roberts EW, Pfau ML, Rodman JR, Bankiewicz KS, Larson PS. Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Neurology. PMID 34649873 DOI: 10.1212/WNL.0000000000012952 |
0.39 |
|
| 2021 |
Merola A, Kobayashi N, Romagnolo A, Wright BA, Artusi CA, Imbalzano G, Litvan I, Van Laar AD, Bankiewicz K. Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. Frontiers in Neurology. 12: 648532. PMID 33889127 DOI: 10.3389/fneur.2021.648532 |
0.314 |
|
| 2020 |
Lonser RR, Akhter AS, Zabek M, Elder JB, Bankiewicz KS. Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders. Journal of Neurosurgery. 1-13. PMID 32915526 DOI: 10.3171/2020.4.JNS20701 |
0.315 |
|
| 2020 |
Richardson RM, Bankiewicz KS, Christine CW, Van Laar AD, Gross RE, Lonser R, Factor SA, Kostyk SK, Kells AP, Ravina B, Larson PS. Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32732384 DOI: 10.1136/Jnnp-2020-322904 |
0.497 |
|
| 2020 |
Nutt JG, Curtze C, Hiller A, Anderson S, Larson PS, Van Laar AD, Richardson RM, Thompson ME, Sedkov A, Leinonen M, Ravina B, Bankiewicz KS, Christine CW. Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32149427 DOI: 10.1002/Mds.27993 |
0.431 |
|
| 2019 |
Heiss JD, Lungu C, Hammoud DA, Herscovitch P, Ehrlich DJ, Argersinger DP, Sinharay S, Scott G, Wu T, Federoff HJ, Zaghloul KA, Hallett M, Lonser RR, Bankiewicz KS. Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31145831 DOI: 10.1002/Mds.27724 |
0.307 |
|
| 2019 |
Christine CW, Bankiewicz KS, Van Laar AD, Richardson RM, Ravina B, Kells AP, Boot B, Martin AJ, Nutt J, Thompson ME, Larson PS. MRI-guided Phase 1 Trial of Putaminal AADC Gene Therapy for Parkinson's Disease. Annals of Neurology. PMID 30802998 DOI: 10.1002/Ana.25450 |
0.441 |
|
| 2019 |
Samaranch L, Ohno K, San Sebastian W, Bankiewicz K. Cerebellomedullary Cistern Injection of Viral Vectors in Nonhuman Primates. Methods in Molecular Biology (Clifton, N.J.). 1937: 313-324. PMID 30706407 DOI: 10.1007/978-1-4939-9065-8_21 |
0.403 |
|
| 2019 |
Kumar K, Butowski N, Aghi M, Bankiewicz K, Bringas J, Bush NAO, Chang S, Clarke J, Taylor J, Martin A, Berger M. Scidot-02. A Phase I Study Of Convection-Enhanced Delivery Of Liposomal-Irinotecan (Onivyde) Using Real-Time Imaging With Gadolinium In Patients With Recurrent High Grade Gliomas: Results Thus Far Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.1143 |
0.306 |
|
| 2019 |
Sampson J, Achrol AS, Aghi M, Bankiewicz K, Brem S, Brenner A, Butowski N, Chandhasin C, Chowdhary S, Coello M, Floyd JR, Kesari S, Merchant F, Merchant N, Randazzo D, et al. Atim-30. Combating Recurrent Glioblastoma With Mdna55, An Interleukin-4 Receptor Targeted Immunotherapy, Through Mri-Guided Convective Delivery Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.029 |
0.327 |
|
| 2018 |
Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Gene therapy for neurological disorders: progress and prospects. Nature Reviews. Drug Discovery. PMID 30093643 DOI: 10.1038/Nrd.2018.110 |
0.323 |
|
| 2018 |
Luz M, Allen PC, Bringas J, Boiko C, Stockinger DE, Nikula KJ, Lewis O, Woolley M, Fibiger HC, Bankiewicz K, Mohr E. Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity. Archives of Toxicology. PMID 29785638 DOI: 10.1007/S00204-018-2222-Z |
0.383 |
|
| 2018 |
Achrol A, Bexon M, Bankiewicz K, Brenner AJ, Butowski N, Kesari S, Merchant F, Merchant R, Randazzo D, Vogelbaum M, Zabek M, Sampson J. Atim-05. Intratumoral Delivery Of Mdna55, An Interleukin-4 Receptor Targeted Immunotherapy, By Mri-Guided Convective Delivery For The Treatment Of Recurrent Glioblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.002 |
0.351 |
|
| 2017 |
Louis N, Liu S, He X, Drummond DC, Noble CO, Goldman S, Mueller S, Bankiewicz K, Gupta N, Hashizume R. New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model. Journal of Neuro-Oncology. PMID 29170909 DOI: 10.1007/S11060-017-2681-8 |
0.419 |
|
| 2017 |
Yazdan-Shahmorad A, Tian N, Kharazia V, Samaranch L, Kells A, Bringas J, He J, Bankiewicz K, Sabes PN. Widespread Optogenetic Expression in Macaque Cortex Obtained with MR-Guided, Convection Enhanced Delivery (CED) of AAV vector to the Thalamus. Journal of Neuroscience Methods. PMID 29042259 DOI: 10.1016/J.Jneumeth.2017.10.009 |
0.317 |
|
| 2017 |
Bankiewicz K, Achrol A, Aghi M, Bexon M, Brenner A, Butowski N, Elder B, Floyd J, Lonser R, Merchant F, Rosemina M, Patel TR, Randazzo D, Souweidane M, Vogelbaum M, et al. Atim-16. Mri-Guided Convective Delivery Of Mdna55, An Interleukin-4 Receptor Targeted Immunotherapy For The Treatment Of Recurrent Glioblastoma Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.111 |
0.327 |
|
| 2016 |
Dreisig K, Degn M, Sund L, Hadaczek P, Samaranch L, San Sebastian W, Bankiewicz K, Rahbek Kornum B. Validation of antibodies for neuroanatomical localization of the P2Y11 receptor in macaque brain. Journal of Chemical Neuroanatomy. 78: 25-33. PMID 27515691 DOI: 10.1016/J.Jchemneu.2016.08.002 |
0.323 |
|
| 2016 |
Han SJ, Bankiewicz K, Butowski NA, Larson PS, Aghi MK. Interventional MRI-guided catheter placement and real time drug delivery to the central nervous system. Expert Review of Neurotherapeutics. PMID 27054877 DOI: 10.1080/14737175.2016.1175939 |
0.403 |
|
| 2016 |
Jahangiri A, Chin AT, Flanigan PM, Chen R, Bankiewicz K, Aghi MK. Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies. Journal of Neurosurgery. 1-10. PMID 27035164 DOI: 10.3171/2016.1.Jns151591 |
0.416 |
|
| 2016 |
Bankiewicz KS, Sudhakar V, Samaranch L, San Sebastian W, Bringas J, Forsayeth J. AAV viral vector delivery to the brain by shape-conforming MR-guided infusions. Journal of Controlled Release : Official Journal of the Controlled Release Society. 240: 434-442. PMID 26924352 DOI: 10.1016/j.jconrel.2016.02.034 |
0.358 |
|
| 2016 |
Rowland NC, Kalia SK, Kalia LV, Larson PS, Lim DA, Bankiewicz KS. Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease. Molecular Therapy. Methods & Clinical Development. 3: 15051. PMID 26817024 DOI: 10.1038/Mtm.2015.51 |
0.306 |
|
| 2016 |
Samaranch L, Bringas J, Pivirotto P, Sebastian WS, Forsayeth J, Bankiewicz K. Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates. Human Gene Therapy Methods. 27: 13-6. PMID 26757202 DOI: 10.1089/Hgtb.2015.129 |
0.381 |
|
| 2016 |
Salegio EA, Bringas J, Bankiewicz KS. MRI-Guided Delivery of Viral Vectors. Methods in Molecular Biology (Clifton, N.J.). 1382: 217-30. PMID 26611589 DOI: 10.1007/978-1-4939-3271-9_15 |
0.304 |
|
| 2016 |
Yang X, Saito R, Nakamura T, Zhang R, Sonoda Y, Kumabe T, Forsayeth J, Bankiewicz K, Tominaga T. Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor. Drug Delivery. 23: 781-6. PMID 24865286 DOI: 10.3109/10717544.2014.914987 |
0.314 |
|
| 2016 |
Evers M, Miniarikova J, Blits B, Spronck L, Brouwers C, Déglon N, Motlik J, Bankiewicz K, Southwell A, Haan Md, Richard C, Petry H, Konstantinova P. L4 Sustained and strong HTT silencing by AAV5-miHTT as therapy for huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A91.2-A91. DOI: 10.1136/Jnnp-2016-314597.259 |
0.442 |
|
| 2016 |
Han S, Taylor J, Aghi M, Chang S, Clarke J, Bankiewicz K, Martin A, Drummond D, Fitzgerald J, Butowski N. ACTR-33. A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA Neuro-Oncology. 18: vi9-vi9. DOI: 10.1093/Neuonc/Now212.031 |
0.304 |
|
| 2015 |
Ciesielska A, Sharma N, Beyer J, Forsayeth J, Bankiewicz K. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats. Plos One. 10: e0122708. PMID 25860990 DOI: 10.1371/Journal.Pone.0122708 |
0.363 |
|
| 2015 |
Hadaczek P, Wu G, Sharma N, Ciesielska A, Bankiewicz K, Davidow AL, Lu ZH, Forsayeth J, Ledeen RW. GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model. Experimental Neurology. 263: 177-89. PMID 25448159 DOI: 10.1016/J.Expneurol.2014.10.010 |
0.345 |
|
| 2015 |
Samaranch L, Hadaczek P, Kells AP, Bringas J, Stockinger D, San Sebastian W, Macayan M, Samineni S, Pivirotto P, Forsayeth J, Bankiewicz K. 647. Repeated Infusion of AAV2-hAADC Into the Thalamus of Non-Human Primates: Effect of Anti-AAV2 Antibodies on Transgene Expression Molecular Therapy. 23: S257-S258. DOI: 10.1016/S1525-0016(16)34256-3 |
0.377 |
|
| 2015 |
Samaranch L, Blits B, Bringas J, Macayan M, Green F, San Sebastian W, Forsayeth J, Bankiewicz K. 545. Strong Cortico-Spinal Transduction After AAV5 Delivery into the Central Nervous System of Nonhuman Primates Molecular Therapy. 23: S219. DOI: 10.1016/S1525-0016(16)34154-5 |
0.364 |
|
| 2015 |
Ciesielska A, Hadaczek P, Beyer J, Forsayeth J, Bankiewicz K. 454. Prior AAV2-hIL10 Infusion Decreases AAV9-Dependent Immunotoxicity in Rat Brain Molecular Therapy. 23: S180. DOI: 10.1016/S1525-0016(16)34063-1 |
0.358 |
|
| 2014 |
Burnett R, Ibañez CE, Pettersson PL, Chen CI, Parab S, Huang T, Robbins J, Bankiewicz K, Aghi M, Logg C, Kasahara N, Pertschuk D, Gruber HE, Jolly DJ. Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids. Molecular Therapy. Methods & Clinical Development. 1: 14024. PMID 26015967 DOI: 10.1038/Mtm.2014.24 |
0.378 |
|
| 2014 |
San Sebastian W, Kells AP, Bringas J, Samaranch L, Hadaczek P, Ciesielska A, Macayan M, Pivirotto PJ, Forsayeth J, Osborne S, Wright JF, Green F, Heller G, Bankiewicz KS. SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE. Molecular Therapy. Methods & Clinical Development. 3. PMID 25541617 DOI: 10.1038/mtm.2014.49 |
0.325 |
|
| 2014 |
Ahn M, Bajsarowicz K, Oehler A, Lemus A, Bankiewicz K, DeArmond SJ. Convection-enhanced delivery of AAV2-PrPshRNA in prion-infected mice. Plos One. 9: e98496. PMID 24866748 DOI: 10.1371/Journal.Pone.0098496 |
0.346 |
|
| 2014 |
Park I, Larson PE, Tropp JL, Carvajal L, Reed G, Bok R, Robb F, Bringas J, Kells A, Pivirotto P, Bankiewicz K, Vigneron DB, Nelson SJ. Dynamic hyperpolarized carbon-13 MR metabolic imaging of nonhuman primate brain. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 71: 19-25. PMID 24346964 DOI: 10.1002/Mrm.25003 |
0.315 |
|
| 2014 |
Han S, Martin A, Berger M, Prados M, Chang S, Clarke J, Bankiewicz K, Butowski N. AT-25 * A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA Neuro-Oncology. 16: v14-v14. DOI: 10.1093/Neuonc/Nou237.25 |
0.372 |
|
| 2013 |
Dube N, Shu JY, Dong H, Seo JW, Ingham E, Kheirolomoom A, Chen PY, Forsayeth J, Bankiewicz K, Ferrara KW, Xu T. Evaluation of doxorubicin-loaded 3-helix micelles as nanocarriers. Biomacromolecules. 14: 3697-705. PMID 24050265 DOI: 10.1021/Bm4010518 |
0.316 |
|
| 2013 |
Chen PY, Ozawa T, Drummond DC, Kalra A, Fitzgerald JB, Kirpotin DB, Wei KC, Butowski N, Prados MD, Berger MS, Forsayeth JR, Bankiewicz K, James CD. Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts. Neuro-Oncology. 15: 189-97. PMID 23262509 DOI: 10.1093/Neuonc/Nos305 |
0.377 |
|
| 2012 |
Salegio EA, Samaranch L, Jenkins RW, Clarke CJ, Lamarre C, Beyer J, Kells AP, Bringas J, Sebastian WS, Richardson RM, Rosenbluth KH, Hannun YA, Bankiewicz KS, Forsayeth J. Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain. Human Gene Therapy. 23: 891-902. PMID 22574943 DOI: 10.1089/Hum.2012.052 |
0.446 |
|
| 2012 |
Salegio EA, Samaranch L, Kells AP, Forsayeth J, Bankiewicz K. Guided delivery of adeno-associated viral vectors into the primate brain. Advanced Drug Delivery Reviews. 64: 598-604. PMID 22036906 DOI: 10.1016/J.Addr.2011.10.005 |
0.407 |
|
| 2012 |
Kells AP, Forsayeth J, Bankiewicz KS. Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain. Neurobiology of Disease. 48: 228-35. PMID 22019719 DOI: 10.1016/j.nbd.2011.10.004 |
0.367 |
|
| 2012 |
San Sebastian W, Richardson RM, Kells AP, Lamarre C, Bringas J, Pivirotto P, Salegio EA, Dearmond SJ, Forsayeth J, Bankiewicz KS. Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum. Human Gene Therapy. 23: 210-7. PMID 22017504 DOI: 10.1089/Hum.2011.162 |
0.47 |
|
| 2011 |
Ziegler RJ, Salegio EA, Dodge JC, Bringas J, Treleaven CM, Bercury SD, Tamsett TJ, Shihabuddin L, Hadaczek P, Fiandaca M, Bankiewicz K, Scheule RK. Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion. Experimental Neurology. 231: 261-71. PMID 21777586 DOI: 10.1016/J.Expneurol.2011.06.019 |
0.358 |
|
| 2011 |
Richardson RM, Kells AP, Martin AJ, Larson PS, Starr PA, Piferi PG, Bates G, Tansey L, Rosenbluth KH, Bringas JR, Berger MS, Bankiewicz KS. Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotactic and Functional Neurosurgery. 89: 141-51. PMID 21494065 DOI: 10.1159/000323544 |
0.466 |
|
| 2011 |
Richardson RM, Gimenez F, Salegio EA, Su X, Bringas J, Berger MS, Bankiewicz KS. T2 imaging in monitoring of intraparenchymal real-time convection-enhanced delivery Neurosurgery. 69: 154-163. PMID 21430597 DOI: 10.1227/Neu.0B013E318217217E |
0.388 |
|
| 2011 |
Richardson RM, Kells AP, Rosenbluth KH, Salegio EA, Fiandaca MS, Larson PS, Starr PA, Martin AJ, Lonser RR, Federoff HJ, Forsayeth JR, Bankiewicz KS. Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1048-57. PMID 21343917 DOI: 10.1038/Mt.2011.11 |
0.468 |
|
| 2011 |
Fiandaca MS, Salegio EA, Yin D, Richardson RM, Valles FE, Larson PS, Starr PA, Lonser RR, Bankiewicz KS. Human/nonhuman primate AC-PC ratio--considerations for translational brain measurements. Journal of Neuroscience Methods. 196: 124-30. PMID 21185868 DOI: 10.1016/J.Jneumeth.2010.12.023 |
0.353 |
|
| 2011 |
Gimenez F, Krauze MT, Valles F, Hadaczek P, Bringas J, Sharma N, Forsayeth J, Bankiewicz KS. Image-guided convection-enhanced delivery of GDNF protein into monkey putamen. Neuroimage. 54: S189-95. PMID 20080195 DOI: 10.1016/j.neuroimage.2010.01.023 |
0.338 |
|
| 2010 |
Su X, Kells AP, Salegio EA, Richardson RM, Hadaczek P, Beyer J, Bringas J, Pivirotto P, Forsayeth J, Bankiewicz KS. Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1490-1495. PMID 28178508 DOI: 10.1038/mt.2010.114 |
0.464 |
|
| 2010 |
Fiandaca MS, Bankiewicz KS. Gene therapy for Parkinson's disease: from non-human primates to humans. Current Opinion in Molecular Therapeutics. 12: 519-29. PMID 20886383 |
0.325 |
|
| 2010 |
Valles F, Fiandaca MS, Eberling JL, Starr PA, Larson PS, Christine CW, Forsayeth J, Richardson RM, Su X, Aminoff MJ, Bankiewicz KS. Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery. 67: 1377-85. PMID 20871425 DOI: 10.1227/Neu.0B013E3181F53A5C |
0.444 |
|
| 2010 |
Su X, Kells AP, Salegio EA, Salegio EA, Richardson RM, Hadaczek P, Beyer J, Bringas J, Pivirotto P, Forsayeth J, Bankiewicz KS. Real-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1490-5. PMID 20551915 DOI: 10.1038/Mt.2010.114 |
0.464 |
|
| 2010 |
Kato T, Natsume A, Toda H, Iwamizu H, Sugita T, Hachisu R, Watanabe R, Yuki K, Motomura K, Bankiewicz K, Wakabayashi T. Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. Gene Therapy. 17: 1363-71. PMID 20520650 DOI: 10.1038/Gt.2010.88 |
0.372 |
|
| 2010 |
Salegio EA, Kells AP, Richardson RM, Hadaczek P, Forsayeth J, Bringas J, Sardi SP, Passini MA, Shihabuddin LS, Cheng SH, Fiandaca MS, Bankiewicz KS. Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders. Human Gene Therapy. 21: 1093-103. PMID 20408734 DOI: 10.1089/hum.2010.040 |
0.486 |
|
| 2010 |
Yin D, Richardson RM, Fiandaca MS, Bringas J, Forsayeth J, Berger MS, Bankiewicz KS. Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics. Journal of Neurosurgery. 113: 240-8. PMID 20367078 DOI: 10.3171/2010.2.Jns091744 |
0.44 |
|
| 2010 |
Marina M, Hadaczek P, Forsayeth J, Bankiewicz K. Abstract 4193: Treatment of malignant gliomas with systemic rapamycin and convection-enhanced delivery of nanoliposomal CPT-11 Cancer Research. 70: 4193-4193. DOI: 10.1158/1538-7445.Am10-4193 |
0.373 |
|
| 2009 |
Krauze MT, Forsayeth J, Yin D, Bankiewicz KS. Convection-enhanced delivery of liposomes to primate brain. Methods in Enzymology. 465: 349-62. PMID 19913176 DOI: 10.1016/S0076-6879(09)65018-7 |
0.301 |
|
| 2009 |
Varenika V, Kells AP, Valles F, Hadaczek P, Forsayeth J, Bankiewicz KS. Controlled dissemination of AAV vectors in the primate brain. Progress in Brain Research. 175: 163-72. PMID 19660655 DOI: 10.1016/S0079-6123(09)17511-8 |
0.32 |
|
| 2009 |
Richardson RM, Varenika V, Forsayeth JR, Bankiewicz KS. Future applications: gene therapy. Neurosurgery Clinics of North America. 20: 205-10. PMID 19555883 DOI: 10.1016/j.nec.2009.04.004 |
0.458 |
|
| 2009 |
Hadaczek P, Forsayeth J, Mirek H, Munson K, Bringas J, Pivirotto P, McBride JL, Davidson BL, Bankiewicz KS. Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Human Gene Therapy. 20: 225-37. PMID 19292604 DOI: 10.1089/Hum.2008.151 |
0.323 |
|
| 2009 |
Johnston LC, Eberling J, Pivirotto P, Hadaczek P, Federoff HJ, Forsayeth J, Bankiewicz KS. Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys. Human Gene Therapy. 20: 497-510. PMID 19203243 DOI: 10.1089/Hum.2008.137 |
0.308 |
|
| 2009 |
Fiandaca MS, Varenika V, Eberling J, McKnight T, Bringas J, Pivirotto P, Beyer J, Hadaczek P, Bowers W, Park J, Federoff H, Forsayeth J, Bankiewicz KS. Real-time MR imaging of adeno-associated viral vector delivery to the primate brain Neuroimage. 47: T27-T35. PMID 19095069 DOI: 10.1016/J.Neuroimage.2008.11.012 |
0.307 |
|
| 2009 |
Yin D, Valles FE, Fiandaca MS, Forsayeth J, Larson P, Starr P, Bankiewicz KS. Striatal volume differences between non-human and human primates. Journal of Neuroscience Methods. 176: 200-5. PMID 18809434 DOI: 10.1016/j.jneumeth.2008.08.027 |
0.357 |
|
| 2008 |
Richardson RM, Larson PS, Bankiewicz KS. Gene and cell delivery to the degenerated striatum: status of preclinical efforts in primate models. Neurosurgery. 63: 629-442; dicussion 6. PMID 18981876 DOI: 10.1227/01.Neu.0000325491.89984.Ce |
0.45 |
|
| 2008 |
Varenika V, Dickinson P, Bringas J, LeCouteur R, Higgins R, Park J, Fiandaca M, Berger M, Sampson J, Bankiewicz K. Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery. Journal of Neurosurgery. 109: 874-80. PMID 18976077 DOI: 10.3171/Jns/2008/109/11/0874 |
0.403 |
|
| 2008 |
Kikuchi T, Saito R, Sugiyama S, Yamashita Y, Kumabe T, Krauze M, Bankiewicz K, Tominaga T. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models. Journal of Neurosurgery. 109: 867-73. PMID 18976076 DOI: 10.3171/Jns/2008/109/11/0867 |
0.355 |
|
| 2008 |
Herzog CD, Dass B, Gasmi M, Bakay R, Stansell JE, Tuszynski M, Bankiewicz K, Chen EY, Chu Y, Bishop K, Kordower JH, Bartus RT. Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatum. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1737-44. PMID 18728639 DOI: 10.1038/Mt.2008.170 |
0.405 |
|
| 2008 |
Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, Guschin D, Hadaczek P, Federoff HJ, Bankiewicz K, Forsayeth J. Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1392-9. PMID 18545225 DOI: 10.1038/Mt.2008.113 |
0.366 |
|
| 2008 |
Cunningham J, Pivirotto P, Bringas J, Suzuki B, Vijay S, Sanftner L, Kitamura M, Chan C, Bankiewicz KS. Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1267-75. PMID 18523450 DOI: 10.1038/Mt.2008.111 |
0.327 |
|
| 2008 |
Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology. 70: 1980-3. PMID 18401019 DOI: 10.1212/01.Wnl.0000312381.29287.Ff |
0.31 |
|
| 2008 |
Fiandaca MS, Forsayeth JR, Dickinson PJ, Bankiewicz KS. Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 5: 123-7. PMID 18164491 DOI: 10.1016/j.nurt.2007.10.064 |
0.38 |
|
| 2008 |
Fiandaca M, Forsayeth J, Bankiewicz K. Current status of gene therapy trials for Parkinson's disease. Experimental Neurology. 209: 51-7. PMID 17920059 DOI: 10.1016/J.Expneurol.2007.08.009 |
0.363 |
|
| 2006 |
Krauze MT, Forsayeth J, Park JW, Bankiewicz KS. Real-time imaging and quantification of brain delivery of liposomes. Pharmaceutical Research. 23: 2493-504. PMID 16972184 DOI: 10.1007/s11095-006-9103-5 |
0.31 |
|
| 2006 |
Hadaczek P, Yamashita Y, Mirek H, Tamas L, Bohn MC, Noble C, Park JW, Bankiewicz K. The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 69-78. PMID 16650807 DOI: 10.1016/J.Ymthe.2006.02.018 |
0.316 |
|
| 2006 |
Hadaczek P, Kohutnicka M, Krauze MT, Bringas J, Pivirotto P, Cunningham J, Bankiewicz K. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Human Gene Therapy. 17: 291-302. PMID 16544978 DOI: 10.1089/Hum.2006.17.291 |
0.453 |
|
| 2006 |
Passini MA, Bu J, Dodge JC, Shihabuddin LS, Taksir TV, Griffiths DA, Bringas J, Hadaczek P, Avramut M, Cheng SH, Bankiewicz K. 2. Identification of Different Modes of Viral Transport in the Non-Human Primate Brain after Convection-Enhanced Delivery of AAV Serotype Vectors Molecular Therapy. 13: S1. DOI: 10.1016/J.Ymthe.2006.08.012 |
0.378 |
|
| 2005 |
Krauze MT, Saito R, Noble C, Tamas M, Bringas J, Park JW, Berger MS, Bankiewicz K. Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. Journal of Neurosurgery. 103: 923-9. PMID 16304999 DOI: 10.3171/Jns.2005.103.5.0923 |
0.347 |
|
| 2005 |
Saito R, Krauze MT, Bringas JR, Noble C, McKnight TR, Jackson P, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Hong K, Berger MS, Park JW, Bankiewicz KS. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Experimental Neurology. 196: 381-9. PMID 16197944 DOI: 10.1016/J.Expneurol.2005.08.016 |
0.322 |
|
| 2005 |
Krauze MT, Mcknight TR, Yamashita Y, Bringas J, Noble CO, Saito R, Geletneky K, Forsayeth J, Berger MS, Jackson P, Park JW, Bankiewicz KS. Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Research. Brain Research Protocols. 16: 20-6. PMID 16181805 DOI: 10.1016/J.Brainresprot.2005.08.003 |
0.308 |
|
| 2005 |
Krauze MT, Saito R, Noble C, Bringas J, Forsayeth J, McKnight TR, Park J, Bankiewicz KS. Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen. Experimental Neurology. 196: 104-11. PMID 16109410 DOI: 10.1016/J.Expneurol.2005.07.009 |
0.342 |
|
| 2005 |
Hadaczek P, Mirek H, Berger MS, Bankiewicz K. Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclovir gene therapy for brain tumors. Journal of Neurosurgery. 102: 328-35. PMID 15739562 DOI: 10.3171/Jns.2005.102.2.0328 |
0.392 |
|
| 2005 |
Hadaczek P, Daadi M, Bankiewicz K. Gene Therapy for Parkinson's Disease Neurologia. 22: 213-245. DOI: 10.1159/000084464 |
0.37 |
|
| 2000 |
Qureshi NH, Bankiewicz KS, Louis DN, Hochberg FH, Chiocca EA, Harsh GR. Multicolumn infusion of gene therapy cells into human brain tumors: technical report. Neurosurgery. 46: 663-8; discussion 66. PMID 10719863 DOI: 10.1097/00006123-200003000-00027 |
0.322 |
|
| 1991 |
Herkenham M, Little MD, Bankiewicz K, Yang SC, Markey SP, Johannessen JN. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience. 40: 133-58. PMID 2052148 DOI: 10.1016/0306-4522(91)90180-V |
0.303 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2012 |
Fiandaca MS, Bankiewicz KS, Federoff HJ. Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel, Switzerland). 5: 553-90. PMID 24281662 DOI: 10.3390/Ph5060553 |
0.296 |
|
| 2009 |
Valles F, Fiandaca MS, Bringas J, Dickinson P, LeCouteur R, Higgins R, Berger M, Forsayeth J, Bankiewicz KS. Anatomic compression caused by high-volume convection-enhanced delivery to the brain. Neurosurgery. 65: 579-85; discussion 5. PMID 19687704 DOI: 10.1227/01.Neu.0000350229.77462.2F |
0.296 |
|
| 2012 |
Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, Lamarre C, Forsayeth J, Kaspar BK, Bankiewicz KS. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Human Gene Therapy. 23: 382-9. PMID 22201473 DOI: 10.1089/Hum.2011.200 |
0.293 |
|
| 2012 |
Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS. Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Human Gene Therapy. 23: 377-81. PMID 22424171 DOI: 10.1089/Hum.2011.220 |
0.291 |
|
| 2014 |
Ryapolova-Webb E, Afshar P, Stanslaski S, Denison T, de Hemptinne C, Bankiewicz K, Starr PA. Chronic cortical and electromyographic recordings from a fully implantable device: preclinical experience in a nonhuman primate. Journal of Neural Engineering. 11: 016009. PMID 24445430 DOI: 10.1088/1741-2560/11/1/016009 |
0.291 |
|
| 2011 |
Yin D, Valles FE, Fiandaca MS, Bringas J, Gimenez F, Berger MS, Forsayeth J, Bankiewicz KS. Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage. 54: S196-203. PMID 19761848 DOI: 10.1016/j.neuroimage.2009.08.069 |
0.287 |
|
| 2020 |
Fiandaca MS, Lonser RR, Elder JB, Ząbek M, Bankiewicz KS. Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders. Neurologia I Neurochirurgia Polska. PMID 32557526 DOI: 10.5603/PJNNS.a2020.0046 |
0.287 |
|
| 2010 |
Forsayeth J, Bankiewicz KS, Aminoff MJ. Gene therapy for Parkinson's disease: where are we now and where are we going? Expert Review of Neurotherapeutics. 10: 1839-45. PMID 21091315 DOI: 10.1586/ern.10.161 |
0.286 |
|
| 2012 |
Yang FH, Zhang B, Zhou DJ, Bie L, Tom MW, Drummond DC, Nicolaides T, Mueller S, Banerjee A, Park JW, Prados MD, James DC, Gupta N, Hashizume R, Strohbehn GW, ... ... Bankiewicz K, et al. LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 14: vi25-vi37. DOI: 10.1093/Neuonc/Nos222 |
0.283 |
|
| 2012 |
Rosenbluth KH, Eschermann JF, Mittermeyer G, Thomson R, Mittermeyer S, Bankiewicz KS. Analysis of a simulation algorithm for direct brain drug delivery. Neuroimage. 59: 2423-9. PMID 21945468 DOI: 10.1016/j.neuroimage.2011.08.107 |
0.283 |
|
| 2019 |
Samaranch L, Pérez-Cañamás A, Soto-Huelin B, Sudhakar V, Jurado-Arjona J, Hadaczek P, Ávila J, Bringas JR, Casas J, Chen H, He X, Schuchman EH, Cheng SH, Forsayeth J, Bankiewicz KS, et al. Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A. Science Translational Medicine. 11. PMID 31434754 DOI: 10.1126/Scitranslmed.Aat3738 |
0.281 |
|
| 2010 |
Laganiere J, Kells AP, Lai JT, Guschin D, Paschon DE, Meng X, Fong LK, Yu Q, Rebar EJ, Gregory PD, Bankiewicz KS, Forsayeth J, Zhang HS. An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 16469-74. PMID 21147986 DOI: 10.1523/JNEUROSCI.2440-10.2010 |
0.281 |
|
| 2011 |
Fiandaca MS, Berger MS, Bankiewicz KS. The use of convection-enhanced delivery with liposomal toxins in neurooncology Toxins. 3: 369-397. PMID 22069714 DOI: 10.3390/toxins3040369 |
0.28 |
|
| 2010 |
Martínez-Cerdeño V, Noctor SC, Espinosa A, Ariza J, Parker P, Orasji S, Daadi MM, Bankiewicz K, Alvarez-Buylla A, Kriegstein AR. Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats. Cell Stem Cell. 6: 238-50. PMID 20207227 DOI: 10.1016/J.Stem.2010.01.004 |
0.278 |
|
| 2010 |
Yin D, Forsayeth J, Bankiewicz KS. Optimized cannula design and placement for convection-enhanced delivery in rat striatum. Journal of Neuroscience Methods. 187: 46-51. PMID 20026357 DOI: 10.1016/j.jneumeth.2009.12.008 |
0.277 |
|
| 2007 |
Yamashita Y, Krauze MT, Kawaguchi T, Noble CO, Drummond DC, Park JW, Bankiewicz KS. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro-Oncology. 9: 20-8. PMID 17018695 DOI: 10.1215/15228517-2006-016 |
0.276 |
|
| 2013 |
Rosenbluth KH, Martin AJ, Mittermeyer S, Eschermann J, Dickinson PJ, Bankiewicz KS. Rapid inverse planning for pressure-driven drug infusions in the brain. Plos One. 8: e56397. PMID 23457563 DOI: 10.1371/journal.pone.0056397 |
0.276 |
|
| 2008 |
Krauze MT, Vandenberg SR, Yamashita Y, Saito R, Forsayeth J, Noble C, Park J, Bankiewicz KS. Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective. Experimental Neurology. 210: 638-44. PMID 18295759 DOI: 10.1016/J.Expneurol.2007.12.015 |
0.275 |
|
| 2016 |
Hadaczek P, Stanek L, Ciesielska A, Pivirotto P, O'Riordan C, Mastis B, Sebastian WS, Forsayeth J, Cheng SH, Bankiewicz KS, Shihabuddin LS. 621. Widespread Gene Delivery to the Nonhuman Primate Brain for the Treatment of Huntington's Disease Molecular Therapy. 24: S246. DOI: 10.1016/S1525-0016(16)33429-3 |
0.274 |
|
| 2010 |
Hadaczek P, Eberling JL, Pivirotto P, Bringas J, Forsayeth J, Bankiewicz KS. Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1458-61. PMID 20531394 DOI: 10.1038/mt.2010.106 |
0.274 |
|
| 2019 |
Sudhakar V, Naidoo J, Samaranch L, Bringas JR, Lonser RR, Fiandaca MS, Bankiewicz KS. Infuse-as-you-go convective delivery to enhance coverage of elongated brain targets: technical note. Journal of Neurosurgery. 1-8. PMID 31299656 DOI: 10.3171/2019.4.JNS19826 |
0.272 |
|
| 2019 |
Sudhakar V, Mahmoodi A, Bringas JR, Naidoo J, Kells A, Samaranch L, Fiandaca MS, Bankiewicz KS. Development of a novel frameless skull-mounted ball-joint guide array for use in image-guided neurosurgery. Journal of Neurosurgery. 1-10. PMID 30771782 DOI: 10.3171/2018.10.JNS182169 |
0.272 |
|
| 2012 |
Bu J, Ashe KM, Bringas J, Marshall J, Dodge JC, Cabrera-Salazar MA, Forsayeth J, Schuchman EH, Bankiewicz KS, Cheng SH, Shihabuddin LS, Passini MA. Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1893-901. PMID 22828503 DOI: 10.1038/Mt.2012.118 |
0.272 |
|
| 2014 |
Weiss WA, Wong R, Fan Q, Ilkhanizadeh S, Lu M, Beyer J, Dube N, Forsayeth J, Kells A, Xu T, Bankiewicz K, Ducker G, Feldman M, Shokat K. MTOR KINASE INHIBITORS AND APOPTOSIS IN GLIOBLASTOMA Neuro-Oncology. 16: iii31-iii31. DOI: 10.1093/Neuonc/Nou208.31 |
0.271 |
|
| 2007 |
Krauze MT, Noble CO, Kawaguchi T, Drummond D, Kirpotin DB, Yamashita Y, Kullberg E, Forsayeth J, Park JW, Bankiewicz KS. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro-Oncology. 9: 393-403. PMID 17652269 DOI: 10.1215/15228517-2007-019 |
0.268 |
|
| 2006 |
Forsayeth JR, Eberling JL, Sanftner LM, Zhen Z, Pivirotto P, Bringas J, Cunningham J, Bankiewicz KS. A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 571-7. PMID 16781894 DOI: 10.1016/j.ymthe.2006.04.008 |
0.265 |
|
| 2017 |
Samaranch L, Blits B, San Sebastian W, Hadaczek P, Bringas J, Sudhakar V, Macayan M, Pivirotto PJ, Petry H, Bankiewicz KS. MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain. Gene Therapy. 24: 253-261. PMID 28300083 DOI: 10.1038/gt.2017.14 |
0.263 |
|
| 2008 |
Dickinson PJ, LeCouteur RA, Higgins RJ, Bringas JR, Roberts B, Larson RF, Yamashita Y, Krauze M, Noble CO, Drummond D, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS. Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation. Journal of Neurosurgery. 108: 989-98. PMID 18447717 DOI: 10.3171/Jns/2008/108/5/0989 |
0.262 |
|
| 2016 |
Hadaczek P, Stanek L, Ciesielska A, Sudhakar V, Samaranch L, Pivirotto P, Bringas J, O'Riordan C, Mastis B, San Sebastian W, Forsayeth J, Cheng SH, Bankiewicz KS, Shihabuddin LS. Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease. Molecular Therapy. Methods & Clinical Development. 3: 16037. PMID 27408903 DOI: 10.1038/mtm.2016.37 |
0.261 |
|
| 2010 |
Kells AP, Eberling J, Su X, Pivirotto P, Bringas J, Hadaczek P, Narrow WC, Bowers WJ, Federoff HJ, Forsayeth J, Bankiewicz KS. Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 9567-77. PMID 20631185 DOI: 10.1523/Jneurosci.0942-10.2010 |
0.261 |
|
| 2011 |
Rosenbluth KH, Luz M, Mohr E, Mittermeyer S, Bringas J, Bankiewicz KS. Design of an in-dwelling cannula for convection-enhanced delivery. Journal of Neuroscience Methods. 196: 118-23. PMID 21187114 DOI: 10.1016/j.jneumeth.2010.12.022 |
0.259 |
|
| 2009 |
Eberling JL, Kells AP, Pivirotto P, Beyer J, Bringas J, Federoff HJ, Forsayeth J, Bankiewicz KS. Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys. Human Gene Therapy. 20: 511-8. PMID 19254173 DOI: 10.1089/Hum.2008.201 |
0.258 |
|
| 2019 |
Truffaux N, Yang X, Hadaczek P, Bankiewicz K, Damment SJP, Mueller S. Dipg-23. Efficacy Of The Soluble Panobinostat (Mtx110) In Preclinical Diffuse Intrinsic Pontine Glioma (Dipg) Models Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz036.044 |
0.258 |
|
| 2019 |
Ohno K, Samaranch L, Hadaczek P, Bringas JR, Allen PC, Sudhakar V, Stockinger DE, Snieckus C, Campagna MV, San Sebastian W, Naidoo J, Chen H, Forsayeth J, Salegio EA, Hwa GGC, ... Bankiewicz KS, et al. Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates. Molecular Therapy. Methods & Clinical Development. 13: 47-54. PMID 30666308 DOI: 10.1016/j.omtm.2018.12.001 |
0.257 |
|
| 2021 |
Van Laar AD, Van Laar VS, San Sebastian W, Merola A, Bradley Elder J, Lonser RR, Bankiewicz KS. An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function. Journal of Parkinson's Disease. PMID 34366374 DOI: 10.3233/JPD-212724 |
0.256 |
|
| 2011 |
Pavel H, Ajeawung N, Faure R, Poirier D, Kamnasaran D, Ajeawung N, Joshi H, Kamnasaran D, Poirier D, Ajeawung N, Kamnasaran D, Lun X, Zemp F, Sun B, Stechishin O, ... ... Bankiewicz K, et al. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 13: iii107-iii120. DOI: 10.1093/Neuonc/Nor158 |
0.255 |
|
| 2010 |
Dickinson PJ, LeCouteur RA, Higgins RJ, Bringas JR, Larson RF, Yamashita Y, Krauze MT, Forsayeth J, Noble CO, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS. Canine spontaneous glioma: a translational model system for convection-enhanced delivery. Neuro-Oncology. 12: 928-40. PMID 20488958 DOI: 10.1093/Neuonc/Noq046 |
0.255 |
|
| 2021 |
Pearson TS, Gupta N, San Sebastian W, Imamura-Ching J, Viehoever A, Grijalvo-Perez A, Fay AJ, Seth N, Lundy SM, Seo Y, Pampaloni M, Hyland K, Smith E, de Oliveira Barbosa G, Heathcock JC, ... ... Bankiewicz KS, et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nature Communications. 12: 4251. PMID 34253733 DOI: 10.1038/s41467-021-24524-8 |
0.254 |
|
| 2013 |
Ciesielska A, Hadaczek P, Mittermeyer G, Zhou S, Wright JF, Bankiewicz KS, Forsayeth J. Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 158-66. PMID 22929660 DOI: 10.1038/mt.2012.167 |
0.252 |
|
| 2013 |
San Sebastian W, Samaranch L, Kells AP, Forsayeth J, Bankiewicz KS. Gene therapy for misfolding protein diseases of the central nervous system. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 498-510. PMID 23700209 DOI: 10.1007/s13311-013-0191-8 |
0.252 |
|
| 2006 |
Saito R, Krauze MT, Noble CO, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro-Oncology. 8: 205-14. PMID 16723630 DOI: 10.1215/15228517-2006-001 |
0.252 |
|
| 2013 |
San Sebastian W, Samaranch L, Heller G, Kells AP, Bringas J, Pivirotto P, Forsayeth J, Bankiewicz KS. Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Therapy. 20: 1178-83. PMID 24067867 DOI: 10.1038/gt.2013.48 |
0.252 |
|
| 2006 |
Bankiewicz KS, Forsayeth J, Eberling JL, Sanchez-Pernaute R, Pivirotto P, Bringas J, Herscovitch P, Carson RE, Eckelman W, Reutter B, Cunningham J. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 564-70. PMID 16829205 DOI: 10.1016/j.ymthe.2006.05.005 |
0.251 |
|
| 2016 |
Spilman PR, Corset V, Gorostiza O, Poksay KS, Galvan V, Zhang J, Rao R, Peters-Libeu C, Vincelette J, McGeehan A, Dvorak-Ewell M, Beyer J, Campagna J, Bankiewicz K, Mehlen P, et al. Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27060954 DOI: 10.3233/Jad-151046 |
0.248 |
|
| 2017 |
Ciesielska A, Samaranch L, San Sebastian W, Dickson DW, Goldman S, Forsayeth J, Bankiewicz KS. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial. Plos One. 12: e0169965. PMID 28166239 DOI: 10.1371/Journal.Pone.0169965 |
0.247 |
|
| 2009 |
Kells AP, Hadaczek P, Yin D, Bringas J, Varenika V, Forsayeth J, Bankiewicz KS. Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proceedings of the National Academy of Sciences of the United States of America. 106: 2407-11. PMID 19193857 DOI: 10.1073/pnas.0810682106 |
0.246 |
|
| 2018 |
Bexon MF, Achrol A, Bankiewicz K, Brenner A, Butowski N, Kesari S, Merchant F, Merchant R, Randazzo D, Vogelbaum M, Zabek M, Sampson J. Understanding biological activity, tumor response and pseudoprogression in a phase-IIb study of MDNA55 in adults with recurrent or progressive glioblastoma (GB). Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy273.368 |
0.245 |
|
| 2020 |
Barker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells A, Fiandaca MS, Stoessl AJ, Eidelberg D, et al. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. Journal of Parkinson's Disease. PMID 32508331 DOI: 10.3233/Jpd-202004 |
0.244 |
|
| 2016 |
Samaranch L, Hadaczek P, Kells AP, Bringas JR, Stockinger D, San Sebastian W, Macayan M, Samineni S, Pivirotto P, Forsayeth J, Bankiewicz KS. Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response Gene Therapy. 23: 393-398. DOI: 10.1038/gt.2015.87 |
0.242 |
|
| 2012 |
Rosenbluth KH, Martin AJ, Bringas J, Bankiewicz KS. Evaluation of pressure-driven brain infusions in nonhuman primates by intra-operative 7 Tesla MRI. Journal of Magnetic Resonance Imaging : Jmri. 36: 1339-46. PMID 22887937 DOI: 10.1002/jmri.23771 |
0.24 |
|
| 2010 |
Liu Y, Paliwal S, Bankiewicz KS, Bringas JR, Heart G, Mitragotri S, Prausnitz MR. Ultrasound-enhanced drug transport and distribution in the brain. Aaps Pharmscitech. 11: 1005-17. PMID 20532711 DOI: 10.1208/S12249-010-9458-0 |
0.24 |
|
| 2001 |
Sánchez-Pernaute R, Harvey-White J, Cunningham J, Bankiewicz KS. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 324-30. PMID 11592835 DOI: 10.1006/MTHE.2001.0466 |
0.236 |
|
| 2009 |
Grahn AY, Bankiewicz KS, Dugich-Djordjevic M, Bringas JR, Hadaczek P, Johnson GA, Eastman S, Luz M. Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience. Journal of Neuro-Oncology. 95: 185-97. PMID 19466380 DOI: 10.1007/s11060-009-9917-1 |
0.233 |
|
| 2013 |
Yin D, Zhai Y, Gruber HE, Ibanez CE, Robbins JM, Kells AP, Kasahara N, Forsayeth J, Jolly DJ, Bankiewicz KS. Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model. Cancer Gene Therapy. 20: 336-41. PMID 23703472 DOI: 10.1038/Cgt.2013.25 |
0.227 |
|
| 2009 |
Su X, Kells AP, Huang EJ, Lee HS, Hadaczek P, Beyer J, Bringas J, Pivirotto P, Penticuff J, Eberling J, Federoff HJ, Forsayeth J, Bankiewicz KS. Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys. Human Gene Therapy. 20: 1627-40. PMID 19671001 DOI: 10.1089/Hum.2009.103 |
0.224 |
|
| 2014 |
Salegio EA, Streeter H, Dube N, Hadaczek P, Samaranch L, Kells AP, San Sebastian W, Zhai Y, Bringas J, Xu T, Forsayeth J, Bankiewicz KS. Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy. Frontiers in Neuroanatomy. 8: 9. PMID 24672434 DOI: 10.3389/Fnana.2014.00009 |
0.224 |
|
| 2010 |
Hadaczek P, Johnston L, Forsayeth J, Bankiewicz KS. Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain. Neuropharmacology. 58: 1114-21. PMID 20153340 DOI: 10.1016/j.neuropharm.2010.02.002 |
0.222 |
|
| 2011 |
Hadaczek P, Beyer J, Kells A, Narrow W, Bowers W, Federoff HJ, Forsayeth J, Bankiewicz KS. Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system. Plos One. 6: e27728. PMID 22132130 DOI: 10.1371/Journal.Pone.0027728 |
0.221 |
|
| 2006 |
Sampson JH, Akabani G, Friedman AH, Bigner D, Kunwar S, Berger MS, Bankiewicz KS. Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies Neurosurgical Focus. 20: E14. PMID 16709019 DOI: 10.3171/Foc.2006.20.4.9 |
0.221 |
|
| 2013 |
Rosenbluth KH, Gimenez F, Kells AP, Salegio EA, Mittermeyer GM, Modera K, Kohal A, Bankiewicz KS. Automated segmentation tool for brain infusions. Plos One. 8: e64452. PMID 23755125 DOI: 10.1371/journal.pone.0064452 |
0.221 |
|
| 2004 |
Saito R, Bringas JR, Panner A, Tamas M, Pieper RO, Berger MS, Bankiewicz KS. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Research. 64: 6858-62. PMID 15466173 DOI: 10.1158/0008-5472.Can-04-1683 |
0.218 |
|
| 2011 |
Ciesielska A, Mittermeyer G, Hadaczek P, Kells AP, Forsayeth J, Bankiewicz KS. Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 922-7. PMID 21102559 DOI: 10.1038/mt.2010.248 |
0.217 |
|
| 2018 |
Nagahara AH, Wilson BR, Ivasyk I, Kovacs I, Rawalji S, Bringas JR, Pivirotto PJ, Sebastian WS, Samaranch L, Bankiewicz KS, Tuszynski MH. MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates. Gene Therapy. PMID 29535375 DOI: 10.1038/s41434-018-0010-2 |
0.213 |
|
| 2014 |
Samaranch L, San Sebastian W, Kells AP, Salegio EA, Heller G, Bringas JR, Pivirotto P, DeArmond S, Forsayeth J, Bankiewicz KS. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 329-37. PMID 24419081 DOI: 10.1038/mt.2013.266 |
0.213 |
|
| 2006 |
Saito R, Krauze MT, Noble CO, Tamas M, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery. Journal of Neuroscience Methods. 154: 225-32. PMID 16472868 DOI: 10.1016/J.Jneumeth.2005.12.027 |
0.21 |
|
| 2006 |
Noble CO, Krauze MT, Drummond DC, Yamashita Y, Saito R, Berger MS, Kirpotin DB, Bankiewicz KS, Park JW. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Research. 66: 2801-6. PMID 16510602 DOI: 10.1158/0008-5472.Can-05-3535 |
0.203 |
|
| 2006 |
Bankiewicz KS, Daadi M, Pivirotto P, Bringas J, Sanftner L, Cunningham J, Forsayeth JR, Eberling JL. Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys. Experimental Neurology. 197: 363-72. PMID 16337943 DOI: 10.1016/J.Expneurol.2005.10.022 |
0.2 |
|
| 2015 |
Seo JW, Ang J, Mahakian LM, Tam S, Fite B, Ingham ES, Beyer J, Forsayeth J, Bankiewicz KS, Xu T, Ferrara KW. Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26437259 DOI: 10.1016/J.Jconrel.2015.09.057 |
0.2 |
|
| 2020 |
Terse PS, Kells AP, Noker P, Wright JF, Bankiewicz KS. Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson's Disease. International Journal of Toxicology. 1091581820966315. PMID 33131343 DOI: 10.1177/1091581820966315 |
0.198 |
|
| 2018 |
Naidoo J, Stanek LM, Ohno K, Trewman S, Samaranch L, Hadaczek P, O'Riordan C, Sullivan J, San Sebastian W, Bringas JR, Snieckus C, Mahmoodi A, Mahmoodi A, Forsayeth J, Bankiewicz KS, et al. Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30057240 DOI: 10.1016/j.ymthe.2018.07.008 |
0.196 |
|
| 2011 |
Khodr CE, Sapru MK, Pedapati J, Han Y, West NC, Kells AP, Bankiewicz KS, Bohn MC. An α-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons. Brain Research. 1395: 94-107. PMID 21565333 DOI: 10.1016/J.Brainres.2011.04.036 |
0.191 |
|
| 2015 |
Forsayeth J, Bankiewicz KS. Transduction of antigen-presenting cells in the brain by AAV9 warrants caution in preclinical studies. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 612. PMID 25849423 DOI: 10.1038/mt.2015.35 |
0.19 |
|
| 2012 |
Mendiburu-Eliçabe M, Yin D, Hadaczek P, Zhai Y, Forsayeth J, Bankiewicz KS. Systemic rapamycin alone may not be a treatment option for malignant glioma: evidence from an in vivo study. Journal of Neuro-Oncology. 108: 53-8. PMID 22350373 DOI: 10.1007/s11060-012-0804-9 |
0.185 |
|
| 2020 |
Bankiewicz KS, Pasterski T, Kreatsoulas D, Onikijuk J, Mozgiel K, Munjal V, Elder JB, Lonser RR, Zabek M. Use of a novel ball-joint guide array for magnetic resonance imaging-guided cannula placement and convective delivery: technical note. Journal of Neurosurgery. 1-7. PMID 33096525 DOI: 10.3171/2020.6.JNS201564 |
0.185 |
|
| 2015 |
San Sebastian W, Forsayeth J, Samaranch L, Bankiewicz KS. 464. Clinical Development of Gene Therapy for Neurotransmitter Deficiency Disorder Molecular Therapy. 23: S184. DOI: 10.1016/S1525-0016(16)34073-4 |
0.183 |
|
| 2013 |
Samaranch L, Salegio EA, San Sebastian W, Kells AP, Bringas JR, Forsayeth J, Bankiewicz KS. Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Human Gene Therapy. 24: 526-32. PMID 23517473 DOI: 10.1089/hum.2013.005 |
0.18 |
|
| 2014 |
Butowski N, Bankiewicz K, Kells A, Martin A, Berger M, Aghi M, Prados M, Chang S, Clarke J. A PHASE I STUDY OF CONVECTION-ENHANCED DELIVERY OF LIPOSOMAL-IRINOTECAN USING REAL-TIME IMAGING WITH GADOLINIUM IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA Neuro-Oncology. 16: iii13-iii13. DOI: 10.1093/NEUONC/NOU206.46 |
0.178 |
|
| 2018 |
Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Gene therapy for neurological disorders: progress and prospects. Nature Reviews. Drug Discovery. PMID 30206384 DOI: 10.1038/Nrd.2018.158 |
0.178 |
|
| 2023 |
Rocco MT, Akhter AS, Ehrlich DJ, Scott GC, Lungu C, Munjal V, Aquino A, Lonser RR, Fiandaca MS, Hallett M, Heiss JD, Bankiewicz KS. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 37098347 DOI: 10.1016/j.ymthe.2023.04.009 |
0.174 |
|
| 2012 |
Salegio EA, Samaranch L, Kells AP, Mittermeyer G, San Sebastian W, Zhou S, Beyer J, Forsayeth J, Bankiewicz KS. Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Therapy. 20: 348-52. PMID 22418061 DOI: 10.1038/gt.2012.27 |
0.174 |
|
| 2019 |
Butowski NA, Bringas JR, Bankiewicz KS, Aghi MK. Editorial. Chronic convection-enhanced delivery: the next frontier in regional drug infusion for glioblastoma. Journal of Neurosurgery. 1-3. PMID 31374552 DOI: 10.3171/2019.4.JNS19614 |
0.171 |
|
| 2017 |
Su X, Fischer DL, Li X, Bankiewicz K, Sortwell CE, Federoff HJ. Alpha-Synuclein mRNA Is Not Increased. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28522034 DOI: 10.1016/J.Ymthe.2017.04.018 |
0.17 |
|
| 2014 |
Noble CO, Krauze MT, Drummond DC, Forsayeth J, Hayes ME, Beyer J, Hadaczek P, Berger MS, Kirpotin DB, Bankiewicz KS, Park JW. Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors. Nanomedicine (London, England). 9: 2099-108. PMID 24494810 DOI: 10.2217/Nnm.13.201 |
0.168 |
|
| 2007 |
Eberling JL, Bankiewicz KS, O'Neil JP, Jagust WJ. PET 6-[F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates. Frontiers in Human Neuroscience. 1: 9. PMID 18958223 DOI: 10.3389/neuro.09.009.2007 |
0.167 |
|
| 2020 |
He M, Li J, Han H, Borges CA, Neiman G, Røise JJ, Hadaczek P, Mendonsa R, Holm VR, Wilson RC, Bankiewicz K, Zhang Y, Sadlowski CM, Healy K, Riley LW, et al. A traceless linker for aliphatic amines that rapidly and quantitatively fragments after reduction. Chemical Science. 11: 8973-8980. PMID 34123152 DOI: 10.1039/d0sc00929f |
0.163 |
|
| 2013 |
Levine ND, Rademacher DJ, Collier TJ, O'Malley JA, Kells AP, San Sebastian W, Bankiewicz KS, Steece-Collier K. Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain. Journal of Neuroscience Methods. 213: 214-27. PMID 23313849 DOI: 10.1016/J.Jneumeth.2012.12.001 |
0.161 |
|
| 2007 |
Bankiewicz KS, Krauze M, Saito R, Yamashita Y, Noble C, Bringas J, Park J, LeCouteur R, Higgins R, Dickinson P. 8. Use of Real-Time MR Imaging for CED of Nano-particles for Treatment of Brain Tumors(Part 3:Stereotactic surgery, PS2-1 Current Status and Evolution of Multimodality Treatment, The 27^ | Annual Meeting of The Japanese Congress of Neurological Surgeons) Japanese Journal of Neurosurgery. 16: 318. DOI: 10.7887/Jcns.16.318_1
| 0.16 |
|
| 2014 |
Passini MA, Bu J, Richards AM, Treleaven CM, Sullivan JA, O'Riordan CR, Scaria A, Kells AP, Samaranch L, San Sebastian W, Federici T, Fiandaca MS, Boulis NM, Bankiewicz KS, Shihabuddin LS, et al. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy. Human Gene Therapy. 25: 619-30. PMID 24617515 DOI: 10.1089/hum.2014.011 |
0.156 |
|
| 2000 |
Eberling JL, Pivirotto P, Bringas J, Bankiewicz KS. Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys. Experimental Neurology. 165: 342-6. PMID 10993693 DOI: 10.1006/exnr.2000.7470 |
0.156 |
|
| 2018 |
Thomsen GM, Avalos P, Ma AA, Alkaslasi M, Cho N, Wyss L, Vit JP, Godoy M, Suezaki P, Shelest O, Bankiewicz KS, Svendsen CN. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis. Stem Cells (Dayton, Ohio). PMID 29656478 DOI: 10.1002/Stem.2825 |
0.153 |
|
| 1989 |
Perese DA, Ulman J, Viola J, Ewing SE, Bankiewicz KS. A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Research. 494: 285-93. PMID 2528389 DOI: 10.1016/0006-8993(89)90597-0 |
0.15 |
|
| 2016 |
Yang X, Saito R, Nakamura T, Zhang R, Sonoda Y, Kumabe T, Forsayeth J, Bankiewicz K, Tominaga T. Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor Drug Delivery. 23: 781-786. DOI: 10.3109/10717544.2014.914987 |
0.129 |
|
| 2023 |
Ford MM, George BE, Van Laar VS, Holleran KM, Naidoo J, Hadaczek P, Vanderhooft LE, Peck EG, Dawes MH, Ohno K, Bringas J, McBride JL, Samaranch L, Forsayeth JR, Jones SR, ... ... Bankiewicz KS, et al. GDNF gene therapy for alcohol use disorder in male non-human primates. Nature Medicine. 29: 2030-2040. PMID 37580533 DOI: 10.1038/s41591-023-02463-9 |
0.128 |
|
| 2006 |
Kawaguchi T, Yamashita Y, Kanamori M, Endersby R, Bankiewicz KS, Baker SJ, Bergers G, Pieper RO. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Cancer Research. 66: 11331-40. PMID 17145879 DOI: 10.1158/0008-5472.Can-06-1540 |
0.125 |
|
| 2021 |
Saha K, Sontheimer EJ, Brooks PJ, Dwinell MR, Gersbach CA, Liu DR, Murray SA, Tsai SQ, Wilson RC, Anderson DG, Asokan A, Banfield JF, Bankiewicz KS, Bao G, Bulte JWM, et al. The NIH Somatic Cell Genome Editing program. Nature. 592: 195-204. PMID 33828315 DOI: 10.1038/s41586-021-03191-1 |
0.125 |
|
| 2020 |
He M, Li J, Han H, Borges CA, Neiman G, Røise JJ, Hadaczek P, Mendonsa R, Holm VR, Wilson RC, Bankiewicz K, Zhang Y, Sadlowski CM, Healy K, Riley LW, et al. A traceless linker for aliphatic amines that rapidly and quantitatively fragments after reduction Chemical Science. 11: 8973-8980. DOI: 10.1039/D0Sc00929F |
0.119 |
|
| 2011 |
Forsayeth JR, Bankiewicz KS. AAV9: Over the Fence and Into the Woods …. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1006-1007. PMID 28178545 DOI: 10.1038/mt.2011.95 |
0.118 |
|
| 2011 |
Forsayeth JR, Bankiewicz KS. AAV9: over the fence and into the woods . . . Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1006-7. PMID 21629257 DOI: 10.1038/mt.2011.95 |
0.115 |
|
| 2010 |
Mendiburu M, Hadaczek P, Forsayeth J, Bankiewicz K. 269 Intermittent treatment schedules with rapamycin against malignant glioma xenograft model European Journal of Cancer Supplements. 8: 70. DOI: 10.1016/S1359-6349(10)71074-0 |
0.095 |
|
| 2012 |
Mendiburu M, Yin D, Hadaczek P, Zhai Y, Forsayeth J, Bankiewicz K. 1067 Problems With Rapamycin Alone in Glioma Treatment European Journal of Cancer. 48: S257-S258. DOI: 10.1016/s0959-8049(12)71676-3 |
0.056 |
|
| 2015 |
Barak S, Wang J, Ahmadiantehrani S, Ben Hamida S, Kells AP, Forsayeth J, Bankiewicz KS, Ron D. Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse. Addiction Biology. 20: 629-42. PMID 24801661 DOI: 10.1111/Adb.12152 |
0.056 |
|
| Hide low-probability matches. |